The results showed that simultaneous mutation in p53 and Pten loci induced HCC nodules in HBV transgenic mouse as early as 4 months, but failed to induce tumors in wild-type C57 mice even at 8 months’ post injection. The gene discussed is TP53; the disease is hepatocellular carcinoma.